Dacomitinib and Perphenazine
Determining the interaction of Dacomitinib and Perphenazine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Dacomitinib may increase the blood levels and effects of perphenazine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with dacomitinib may increase the plasma concentrations of drugs that are substrates of the CYP450 2D6 isoenzyme. The mechanism is reduced clearance due to inhibition of CYP450 2D6 by dacomitinib. When dextromethorphan, a probe substrate for CYP450 2D6, was coadministered with a single 45 mg dose of dacomitinib, dextromethorphan peak plasma concentration (Cmax) and systemic exposure (AUC) increased by 9.7- and 9.6-fold, respectively. The interaction may be particularly important for sensitive CYP450 2D6 substrates or those that demonstrate a narrow therapeutic index.
MANAGEMENT: Caution is advised if dacomitinib is used in combination with CYP450 2D6 substrates. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate whenever dacomitinib is added to or withdrawn from therapy. Avoid concomitant use with dacomitinib where minimal increases in concentration of the CYP450 2D6 substrate may lead to serious or life-threatening toxicities.
- "Product Information. Vizimpro (dacomitinib)." Pfizer U.S. Pharmaceuticals Group, New York, NY.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dacomitinib-Perphenazine and amitriptyline
- Dacomitinib-Perrigo Benzoyl Peroxide Alcohol Base Gel
- Dacomitinib-Perrigo Benzoyl Peroxide Gel
- Dacomitinib-Perrigo Benzoyl Peroxide Wash
- Dacomitinib-Perrigo Sodium Sulfacetamide and Sulfur
- Dacomitinib-Persa-Gel
- Perphenazine-Dactinomycin
- Perphenazine-Dactinomycin Injection
- Perphenazine-Dactinomycin Intravenous
- Perphenazine-Daklinza
- Perphenazine-Dalacin C Palmitate Oral
- Perphenazine-Dalbavancin